38 /100
MEDIUM RISK
Score updated Jun 11, 2026

AVTX — Avalo Therapeutics, Inc. Dilution Risk Tracker

Track AVTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track AVTX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
25
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for AVTX.
🔔 Track AVTX — Get forecast alerts →

💹 Market Data

Market Cap$838.42M
Shares Outstanding52.57M
Float40.18M
Cash$81.99M
Debt$15.30M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 69.3% shares (2026Q1 vs prior)
101 institutional holders · 36.04M shares
#1 FMR LLC 2.88M shares
#2 T. Rowe Price Investment Management, Inc. 2.16M shares
#3 Caligan Partners LP 1.64M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest6.25M
Days to Cover1.6
% of Float15.6%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2024
4 INSIDER TRANSACTION Apr 08, 2026
4 INSIDER TRANSACTION Apr 03, 2026
4 INSIDER TRANSACTION Apr 03, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track AVTX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking AVTX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

🔬 More Research for AVTX
📊 AVTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 AVTX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.